JMP reiterates Market Outperform rating on Axon Enterprise stock at $825

Investing.com - JMP Securities has reiterated its Market Outperform rating and $825 price target on Axon Enterprise (NASDAQ:AXON) following investor meetings with the company’s Senior Director of Investor Relations. According to InvestingPro analysis, the stock appears overvalued at current levels, despite showing impressive gross profit margins of 60.6%.

The meetings, which took place on Thursday, September 25, focused on several key topics including emerging products, sales strategies, financial dynamics, and the recent Prepared acquisition, according to JMP analyst Trevor Walsh.

Axon stock has gained approximately 19% year-to-date, outperforming the Russell 3000 index which has risen about 12% during the same period.

JMP highlighted the Prepared acquisition as a primary takeaway, describing it as "a perfect complement" to Axon’s previous Fusus and Dedrone acquisitions. Other key discussion points included Axon’s journey toward $600 per officer annually and the company’s preference for reinvesting into new product development.

The investor sessions also addressed Axon’s new enterprise opportunities and customer budget dynamics, with emerging products representing the most common topic, accounting for 22% of questions asked during the meetings.

In other recent news, Axon Enterprise announced its acquisition of Prepared, an AI-powered emergency communications platform, which is expected to close in early Q4. This acquisition aims to enhance Axon’s capabilities in 911 call analytics, although the financial terms were not disclosed, earlier estimates valued the deal at approximately $800 million. Furthermore, Axon has expanded its board of directors by appointing Todd Morgenfeld, who will serve on the Audit Committee and the Mergers and Acquisitions and Capital Structure Committee.

In addition to these developments, Needham reiterated its Buy rating on Axon Enterprise, setting a price target of $870, citing the Prepared acquisition as a growth driver. TD Cowen also maintained a Buy rating with a price target of $925, expressing confidence in Axon’s growth prospects following a recent investor meeting. BofA Securities increased its price target to $1,000, highlighting strong momentum across Axon’s business segments. These updates reflect a period of strategic growth and positive analyst sentiment for Axon Enterprise.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.